Business · 17/08/2011Updated: 10/17/2026 · 1 min read
FDA Withdraws Draft Guidance on Cell Selection Devices for Autologous Blood Stem Cells
Summary
The Food and Drug Administration (FDA) has withdrawn a draft guidance document related to cell selection devices for producing autologous peripheral blood stem cells, which was first published in July 2007.
Original source language: Federal Register — Health and Human ServicesOpen original release →